Minapharm Pharmaceuticals (MIPH)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Egyptian Pound

Market Cap 4,314,997,440.00 Egyptian Pound

Book Value (BVPS) 474.06 Egyptian Pound Based on: Third Quarter 2025

P/B Ratio 0.72 Last update: 2026-02-09

EPS 5.48 Egyptian Pound Based on: Third Quarter 2025

P/E Ratio 20.01 Last update: 2026-02-09

Trading Currency Egyptian Pound

Company Statistics

News

Minapharm’ consolidated net profits retreat to EGP 62m in 9M-25 Financial Results

Minapharm posts EGP 66.5m standalone net profits in 9M-25; sales hit EGP 2.8bn Financial Results

Investor buys EGP 1.3bn stake in Minapharm Pharmaceuticals Trading Activities

Minapharm Pharmaceuticals’ shareholders nod to 2022 dividends General Assembly

Minapharm Pharmaceuticals mulls EGP 603m capital hike Board of Directors

Bioventure, Minapharm, MiGenTra to commercialise multiple biosimilar candidates of Alvotech Macroeconomics

Market Announcements